Rocket Pharmaceuticals (RCKT) Other Working Capital Changes (2014 - 2026)

Rocket Pharmaceuticals has reported Other Working Capital Changes for 2 years, with the latest figure at $18000.0 in Q3 2023.

• Quarterly Other Working Capital Changes rose 251.82% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$913000.0 (down 3869.57% YoY) and the FY2025 annual result came in at -$2.1 million, down 416.04% from the prior year.
• Other Working Capital Changes rose to $1.6 million in Q1 2026 per RCKT's latest filing, from -$1.2 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $4.7 million in Q3 2023 and troughed at -$4.7 million in Q4 2023.
• A 5-year average of $65529.4 and a median of -$354000.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 2302.06% in 2023, then slumped 358.39% in 2025.
• Over 2 years, Other Working Capital Changes stood at -$32000.0 in 2022, then surged by 156.25% to $18000.0 in 2023.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $18000.0, $5000.0, and $97000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.